Fish Oil and Seafood a Plus

SardinesInCanAndOilInBottle.jpg

Open tin of sardines on a wood table with a fork and bottle of oil next to it.
Photo by Towfiqu barbhuiya / Pexels

Total vegetarians or vegans discourage the consumption of all animal flesh, including fish. Others, such as Keith I. Block, MD, advocates “pescetarianism,” and allows or encourages the consumption of healthy fish (devoid of mercury contamination) in an otherwise vegetarian diet. What does science show?

Fish Oil and Chemotherapy

An increase in certain fish oils and vitamins during chemotherapy has repeatedly been associated with a better outcome. Thus, in a phase II clinical trial, the addition of 1.8 grams of docosahexaenoic acid (DHA) per day improved the outcome of chemotherapy.1

Fish oil also prevented bone loss caused by the use of aromatase inhibitors in postmenopausal women.2

Aromatase Inhibitor (AI)

In obese breast cancer patients, use of omega-3 fatty acids (such as those found in fish oil) was associated with significantly reduced aromatase inhibitor (AI) joint pain compared to placebo.3

Other than the risk of overconsuming mercury or other pollutants, we can see no good reason that a person would not consume fish, especially oily fish such as sardines.

For more information go to The Moss Report.

References

  1. Bougnoux P, Hajjaji N, Ferrasson MN, Giraudeau B, Couet C, Le Floch O. Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. Br J Cancer. 2009 Dec 15;101(12):1978-85. doi: 10.1038/sj.bjc.6605441. Epub 2009 Nov 17. PMID: 19920822; PMCID: PMC2779856.
  2. Hutchins-Wiese HL, Picho K, Watkins BA, Li Y, Tannenbaum S, Claffey K, Kenny AM. High-dose eicosapentaenoic acid and docosahexaenoic acid supplementation reduces bone resorption in postmenopausal breast cancer survivors on aromatase inhibitors: a pilot study. Nutr Cancer. 2014;66(1):68-76. doi: 10.1080/01635581.2014.847964. Epub 2013 Nov 25. PMID: 24274259.
  3. Shen S, Unger JM, Crew KD, et al. Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927). Breast Cancer Res Treat. 2018 Dec;172(3):603-610. doi: 10.1007/s10549-018-4946-0. Epub 2018 Aug 29. PMID: 30159789; PMCID: PMC6681817

About the Author

Ralph Moss

Ralph W. Moss, Ph.D., is an author and consultant on cancer treatments. Since 1974 he has been writing about both conventional and non-conventional medicine for cancer patients.

He has written 12 books, 3 film documentaries, and numerous articles in medical journals. He has been an invited lecturer at many medical